stockportfolio.pro
Neurocrine Biosciences, Inc. Shares Outstanding 2009–2025
Neurocrine Biosciences, Inc. (NBIX) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 100.1M | +0.7% |
| FY 2024 | 99.4M | +0.7% |
| FY 2023 | 98.7M | +2.3% |
| FY 2022 | 96.5M | +1.7% |
| FY 2021 | 94.9M | +1.5% |
| FY 2020 | 93.5M | +1.3% |
| FY 2019 | 92.3M | +1.7% |
| FY 2018 | 90.8M | +2.3% |
| FY 2017 | 88.8M | +2.2% |
| FY 2016 | 86.9M | +0.7% |
| FY 2015 | 86.3M | +12.8% |
| FY 2014 | 76.5M | +13.5% |
| FY 2013 | 67.4M | +1.4% |
| FY 2012 | 66.4M | +20.2% |
| FY 2011 | 55.3M | +0.7% |
| FY 2010 | 54.9M | — |
| FY 2009 | 0.0M | — |
Source: Neurocrine Biosciences, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Neurocrine Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeurocrine Biosciences, Inc. — frequently asked questions
What is Neurocrine Biosciences, Inc.'s shares outstanding?
Neurocrine Biosciences, Inc. (NBIX) reported shares outstanding of 100.1M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Neurocrine Biosciences, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.